Daratumumab/Dexamethasone/Selinexor Regimen

Preferred Label : Daratumumab/Dexamethasone/Selinexor Regimen;

NCIt synonyms : Daratumumab/Dexamethasone/Selinexor; Selinexor/Dexamethasone Plus Daratumumab; Selinexor/Dexamethasone Plus Daratumumab Regimen; Daratumumab-Dexamethasone-Selinexor; Daratumumab-Dexamethasone-Selinexor Regimen; Darzalex/Dexamethasone/Xpovio;

NCIt related terms : SDd;

NCIt definition : A regimen consisting of selinexor, dexamethasone and daratumumab that may be used for the treatment of relapsed or refractory plasma cell (multiple) myeloma.;

NCI Metathesaurus CUI : CL1664484;

Codes from synonyms : 61921;

Details

Origin ID

C181569;

UMLS CUI

C5557154;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Daratumumab [NCIt concept]
- Dexamethasone [NCIt concept]
- Selinexor [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients